2015 | | Association of P2RY12 polymorphisms with eosinophil and platelet activation in patients with aspirin-exacerbated respiratory disease. | 김승현, 박해심 |
2017 | | Association of the miR-196a2, miR-146a, and miR-499 Polymorphisms with Asthma Phenotypes in a Korean Population | 김승현, 박해심 |
2018 | | Biological function of eosinophil extracellular traps in patients with severe eosinophilic asthma | 김승현, 박해심, 이소희 |
2023 | | Biomarkers for predicting type 2-high and uncontrolled asthma in real-world practice | 김승현, 박해심, 신유섭, 예영민, 이영수, 장재혁 |
2020 | | Ceramide/sphingosine-1-phosphate imbalance is associated with distinct inflammatory phenotypes of uncontrolled asthma | 김승현, 박해심 |
2012 | | Effect of genetic polymorphism of ALOX15 on aspirin-exacerbated respiratory disease | 김승현, 박해심 |
2021 | | Engineering of Humanized Antibodies Against Human Interleukin 5 Receptor Alpha Subunit That Cause Potent Antibody-Dependent Cell-Mediated Cytotoxicity | 박해심, 정근옥, 최영우 |
2013 | | Eosinophil activation and novel mediators in the aspirin-induced nasal response in AERD. | 김승현, 박해심, 신유섭, 예영민 |
2020 | | Eosinophil extracellular traps activate type 2 innate lymphoid cells through stimulating airway epithelium in severe asthma | 김승현, 박해심, 신유섭, 최영우 |
2019 | | Immunomodulatory function of surfactant protein D in eosinophilic asthma | 김승현, 박해심, 신유섭 |
2017 | | Neutrophil autophagy and extracellular DNA traps contribute to airway inflammation in severe asthma | 김승현, 박해심, 반가영, 신유섭, 예영민, 최용준 |
2022 | | Role of Thymus and Activation-Regulated Chemokine in Allergic Asthma | 김승현, 박해심 |
2013 | | Serum metabolomics reveals pathways and biomarkers associated with asthma pathogenesis. | 김승현, 박해심 |
2019 | | Surfactant protein D alleviates eosinophil-mediated airway inflammation and remodeling in patients with aspirin-exacerbated respiratory disease | 김승현, 박해심, 신유섭 |